Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations
Solventum (NYSE: SOLV) has announced a strategic partnership with SprintRay to revolutionize digital dentistry through same-day permanent restorations. The collaboration combines Solventum's expertise in dental composites and restorative materials with SprintRay's chairside 3D printing technology.
The R&D and commercialization agreement aims to develop the first permanent chairside 3D printed crown, along with inlays and onlays. This partnership promises to reduce patient visits, improve practice efficiency, and lower treatment costs while maintaining the quality expected from traditional laboratory-fabricated procedures.
The announcement aligns with Solventum's growth strategy and follows their recent launch of four new products in 2024, including 3D printed aligner attachments, fluoride treatment, multi-layer copolymer aligners, and universal restorative solutions. More details will be shared at the International Dental Show 2025 in Cologne, Germany.
Solventum (NYSE: SOLV) ha annunciato una partnership strategica con SprintRay per rivoluzionare l'odontoiatria digitale attraverso restauri permanenti in giornata. La collaborazione unisce l'esperienza di Solventum nei compositi dentali e nei materiali restaurativi con la tecnologia di stampa 3D chairside di SprintRay.
L'accordo di R&D e commercializzazione mira a sviluppare la prima corona permanente stampata in 3D chairside, insieme a inlays e onlays. Questa partnership promette di ridurre le visite dei pazienti, migliorare l'efficienza dello studio e abbattere i costi di trattamento, mantenendo la qualità attesa dai tradizionali processi di laboratorio.
L'annuncio si allinea con la strategia di crescita di Solventum e segue il recente lancio di quattro nuovi prodotti nel 2024, tra cui attacchi per allineatori stampati in 3D, trattamento al fluoro, allineatori in copolimero a più strati e soluzioni restaurative universali. Maggiori dettagli saranno condivisi all'International Dental Show 2025 a Colonia, Germania.
Solventum (NYSE: SOLV) ha anunciado una asociación estratégica con SprintRay para revolucionar la odontología digital a través de restauraciones permanentes el mismo día. La colaboración combina la experiencia de Solventum en compuestos dentales y materiales restaurativos con la tecnología de impresión 3D chairside de SprintRay.
El acuerdo de I+D y comercialización tiene como objetivo desarrollar la primera corona permanente impresa en 3D chairside, junto con inlays y onlays. Esta asociación promete reducir las visitas de los pacientes, mejorar la eficiencia de la práctica y disminuir los costos de tratamiento, manteniendo la calidad esperada de los procedimientos fabricados en laboratorio tradicionales.
El anuncio se alinea con la estrategia de crecimiento de Solventum y sigue el reciente lanzamiento de cuatro nuevos productos en 2024, incluidos los accesorios para alineadores impresos en 3D, tratamiento con flúor, alineadores de copolímero de múltiples capas y soluciones restaurativas universales. Se compartirán más detalles en el International Dental Show 2025 en Colonia, Alemania.
솔벤트럼 (NYSE: SOLV)은 스프린트레이와 전략적 파트너십을 체결하여 당일 영구 보철물로 디지털 치과를 혁신한다고 발표했습니다. 이 협력은 솔벤트럼의 치과 복합재 및 복원 재료에 대한 전문성과 스프린트레이의 의자 옆 3D 프린팅 기술을 결합합니다.
연구 개발 및 상업화 계약은 첫 번째 영구 의자 옆 3D 프린트 크라운과 인레이 및 온레이를 개발하는 것을 목표로 합니다. 이 파트너십은 환자 방문을 줄이고, 진료 효율성을 향상시키며, 치료 비용을 낮추면서도 전통적인 실험실 제작 절차에서 기대되는 품질을 유지할 것을 약속합니다.
이 발표는 솔벤트럼의 성장 전략과 일치하며, 2024년에 3D 프린트된 정렬기 부착물, 불소 처리, 다층 코폴리머 정렬기 및 범용 복원 솔루션을 포함한 네 가지 신제품을 최근 출시한 이후 이루어졌습니다. 더 많은 세부 사항은 2025년 독일 쾰른에서 열리는 국제 치과 전시회에서 공유될 예정입니다.
Solventum (NYSE: SOLV) a annoncé un partenariat stratégique avec SprintRay pour révolutionner la dentisterie numérique grâce à des restaurations permanentes le jour même. La collaboration combine l'expertise de Solventum en composites dentaires et en matériaux restaurateurs avec la technologie d'impression 3D en cabinet de SprintRay.
L'accord de R&D et de commercialisation vise à développer la première couronne permanente imprimée en 3D en cabinet, ainsi que des inlays et des onlays. Ce partenariat promet de réduire le nombre de visites des patients, d'améliorer l'efficacité de la pratique et de diminuer les coûts de traitement tout en maintenant la qualité attendue des procédures fabriquées en laboratoire traditionnelles.
L'annonce s'inscrit dans la stratégie de croissance de Solventum et fait suite à leur récent lancement de quatre nouveaux produits en 2024, notamment des attaches d'aligneur imprimées en 3D, un traitement au fluor, des aligneurs en copolymère multicouche et des solutions de restauration universelles. Plus de détails seront partagés lors du Salon Dentaire International 2025 à Cologne, en Allemagne.
Solventum (NYSE: SOLV) hat eine strategische Partnerschaft mit SprintRay angekündigt, um die digitale Zahnmedizin durch sofortige permanente Restaurationen zu revolutionieren. Die Zusammenarbeit vereint Solventums Fachwissen in zahnärztlichen Verbundmaterialien und restaurativen Materialien mit der Chairside-3D-Drucktechnologie von SprintRay.
Die Vereinbarung über Forschung und Entwicklung sowie Kommerzialisierung zielt darauf ab, die erste permanente Chairside-3D-gedruckte Krone sowie Inlays und Onlays zu entwickeln. Diese Partnerschaft verspricht, die Patiententermine zu reduzieren, die Praxiseffizienz zu verbessern und die Behandlungskosten zu senken, während die Qualität beibehalten wird, die von traditionellen im Labor hergestellten Verfahren erwartet wird.
Die Ankündigung steht im Einklang mit Solventums Wachstumsstrategie und folgt auf die kürzliche Einführung von vier neuen Produkten im Jahr 2024, darunter 3D-gedruckte Alignatorbefestigungen, Fluorbehandlungen, mehrschichtige Copolymer-Aligner und universelle Restaurierungslösungen. Weitere Einzelheiten werden auf der Internationalen Dentalmesse 2025 in Köln, Deutschland, bekannt gegeben.
- Strategic partnership to develop first permanent chairside 3D printed crown
- Potential for increased revenue through new market opportunities in digital dentistry
- Successfully launched four new innovative products in 2024
- Technology expected to reduce treatment costs and improve practice efficiency
- Significant R&D investment required for new technology development
- Faces competition in highly competitive dental market
- Success dependent on market acceptance of 3D printed dental solutions
Insights
This partnership between Solventum and SprintRay represents a significant advancement in chairside digital dentistry. The development of permanent 3D-printed crowns addresses a critical friction point in dental practice workflows - the multi-visit requirement for traditional crown procedures.
Current permanent restorations typically require at least two patient visits with laboratory fabrication between appointments. By combining Solventum's expertise in restorative materials (notably their Filtek™ and RelyX™ product lines) with SprintRay's chairside 3D printing technology, this collaboration could fundamentally transform restorative dentistry workflows.
The clinical implications are substantial. Same-day permanent restorations would eliminate provisional crowns, reduce infection risks, and minimize potential fit issues that occur between appointments. For dental practices, this represents operational efficiency - fewer appointments means higher patient throughput and improved chair utilization.
What's particularly notable is that this isn't just about speed but longevity. Previous attempts at chairside restorations have often compromised durability for convenience. Solventum's emphasis on creating restorations "that can last decades" suggests they're targeting the limitations that have historically prevented widespread adoption of chairside-fabricated permanent restorations.
This innovation aligns with the broader industry shift toward digital dentistry, where we're seeing increasing integration between material science and digital fabrication technologies. For dental practitioners evaluating technology investments, this partnership offers a compelling value proposition by potentially delivering both operational efficiency and clinical quality.
This strategic partnership positions Solventum at the forefront of digital transformation in dentistry, targeting the $7.5 billion global dental restoration market. By developing permanent same-day 3D-printed restorations, Solventum is entering a high-margin segment with significant growth potential.
The partnership demonstrates Solventum's execution of its post-3M spinoff strategy. This aligns perfectly with their previously announced three-phased plan, specifically addressing their commitment to "biasing resources towards growth while strengthening digital capabilities." This R&D and commercialization agreement represents a tangible step toward vertical integration in their dental solutions business.
From a competitive standpoint, being first-to-market with permanent chairside 3D-printed crowns creates a meaningful advantage. Solventum can leverage its established dental materials reputation (evidenced by their seven Dental Advisor awards in 2024) while expanding into digital workflows that create recurring revenue opportunities.
The timing is particularly strategic following Solventum's four product launches in 2024, demonstrating continued innovation momentum. This partnership diversifies their growth vectors beyond traditional materials into digital dentistry solutions with potentially higher margins.
While financial terms weren't disclosed, this represents potential long-term value creation through: 1) expanded market reach into chairside applications; 2) higher-value product offerings combining consumables with technology; and 3) strengthened competitive positioning against both traditional dental material companies and digital dentistry startups. The initiative effectively transforms Solventum from a dental materials supplier into a comprehensive solutions provider in the digital dentistry ecosystem.
In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is striving to focus on longevity and durability of permanent same-day restorative dental offerings, reaffirming its commitment to solving industry's toughest problems
Partnership aims to integrate innovative new material science and disruptive technology like chairside 3D printing to optimize workflows, enhance procedural efficiency and benefit both patients and practitioners
Solventum Dental Solutions connects leading-edge materials with data science to help dentists solve their toughest challenges with products such as Filtek™ Easy Match Universal Restorative, Filtek™ Matrix, Scotchbond™ Universal and RelyX™ Universal Cement. SprintRay offers innovative chairside end-to-end 3D printing ecosystems, which create a platform for a wide range of restorative dental applications.
With Solventum's legacy of best-in-class material science with leading restorative materials, and SprintRay's innovative technology, the partnership aims to bring to market the first permanent chairside, 3D printed crown. Together, Solventum and SprintRay anticipate improvement in patient experience and outcomes through fewer office visits – driving practice efficiency, and ultimately, delivering the outcomes patients and providers demand.
"Imagine a world where your dentist can create a crown that can last decades in a matter of minutes," said Karim Mansour, President, Dental Solutions, Solventum. "We believe this partnership will revolutionize the way dentists and orthodontists care for patients with in-office production, offering a simplified procedure that we anticipate will improve outcomes and experiences, reduce chair time and lower treatment costs. This collaboration allows us to integrate the latest technological advancements into our proven restorative solutions, ensuring we remain at the forefront of dental innovation to deliver unparalleled care to our patients."
Offering cutting-edge 3D printing technology directly to dentists and orthodontists will streamline care for patients and providers, allowing the delivery of same-visit dentistry and introducing a market for permanent 3D printed crowns, inlays, onlays and more.
"Together, we can make a significant impact in restorative dentistry by building exceptional products for same-visit treatment," said SprintRay CEO Amir Mansouri. "Our partnership with Solventum is a key collaboration and commitment to making a difference in people's oral health as well as enabling high-quality and cost-effective dental restorations across the globe."
The announcement of the partnership aligns with Solventum's legacy of quality material science and is one example of biasing resources towards growth while strengthening digital capabilities, two elements of Solventum's previously announced three-phased plan. As the winner of seven Dental Advisor awards in 2024, the partnership follows four new product introductions launched in 2024, including:
- 3M™ Clarity™ Precision Grip Attachments, the first 3D printed aligner attachments
- 3M™ Clinpro™ Clear Fluoride Treatment, a new water-based formula for smoother application and a more comfortable patient experience
- Clarity™ Flex + Force Aligners, new proprietary multi-layer copolymer extruded in different thicknesses to best express varying degrees of movement
- 3M™ Filtek™ Easy Match Universal Restorative features naturally adaptive opacity and offers an intuitive shade selection process to simplify direct restorative procedures
Solventum will share more details about the strategic partnership at the International Dental Show (IDS) 2025 on March 26 in
About Solventum
At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com.
Forward-Looking Statements
This news release contains forward-looking information about Solventum's financial results, estimates, and business prospects that involve substantial risks and uncertainties. In particular, statements regarding the future performance of Solventum, including guidance for 2024, are forward-looking statements. You can identify these statements by the use of words such as "anticipates," "believes," "could," "estimates," "expects," "forecasts," "goal," "guidance," "intends," "may," "outlook," "plans," "projects," "seeks," "sees," "should," "targets," "will," "would," and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) the effects of, and changes in, worldwide economic, political, regulatory, international, trade and geopolitical conditions, natural disasters, war, public health crises, and other events beyond Solventum's control; (2) operational execution risks; (3) damage to our reputation or our brands; (4) risks from acquisitions, strategic alliances, divestitures and other strategic events; (5) ; the highly competitive environment in which Solventum operates and consolidation in the healthcare industry; (6) reduction in customers' research budgets or government funding; (7) the timing and market acceptance of Solventum's new product and service offerings; (8) ongoing working relationships with certain key healthcare professionals; (9) changes in reimbursement practices of governments or private payers or other cost containment measures; (10) Solventum's ability to obtain components or raw materials supplied by third parties and other manufacturing and related supply chain difficulties, interruptions, and disruptive factors; (11) risks related to the highly regulated environment in which Solventum operates; (12) Solventum's failure to obtain, maintain, protect, or effectively enforce its intellectual property ("IP") rights.
Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located under "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors" in Solventum's periodic reports on file with the
View original content to download multimedia:https://www.prnewswire.com/news-releases/solventum-partners-with-sprintray-to-disrupt-the-digital-dentistry-market-with-high-quality-permanent-same-day-restorations-302411305.html
SOURCE Solventum
FAQ
What is the main goal of Solventum's (SOLV) partnership with SprintRay?
How will the SOLV-SprintRay partnership benefit dental practices?
What new dental products did Solventum (SOLV) launch in 2024?
When will Solventum (SOLV) share more details about the SprintRay partnership?
